Exo adds AI-powered cardiac, lung apps to handheld ultrasound
Exo announced today that it launched its FDA-cleared cardiac and lung AI applications for the Iris handheld ultrasound device.
Exo announced today that it launched its FDA-cleared cardiac and lung AI applications for the Iris handheld ultrasound device.
Why are doctors so burned out? How common is physician burnout? What causes physician burnout? Is physician burnout increasing? Why is physician wellness imp…
On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade.
Read interviews with seven early career researchers, published in ASHG journals American Journal of Human Genetics and HGG Advances, who describe their career journeys, roadblocks,…
Nature Medicine – A phase 2a trial of LM11A-31 in mild to moderate Alzheimer disease suggests that p75NTR modulation is safe and attenuates measures of…
On this episode of DGTL Voices, Ed welcomes Raki McGregor, the Senior Vice President of New Business, Digital Equity & Community Growth at Novant Health.…
Achieving “purpose congruence,” the alignment of corporate and individual employee purposes, is essential for organizational success. Rather than imposing a uniform corporate mission, businesses should…
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise…
Engineers at the University of California San Diego have developed a wearable ultrasound patch that can offer continuous, non-invasive monitoring of blood flow in the…
A study of a diet and exercise intervention for women with breast cancer found no difference in chemotherapy completion rates but a significant improvement in…
Covid and the Future of Health: How innovative patients are changing medicine